Clinical Report: Trends in the Utilization of High-Flow Nasal Cannula and CPAP
Overview
This study evaluates the use of high-flow nasal cannula (HFNC) and continuous positive airway pressure (CPAP) for treating bronchiolitis in infants across five hospitals in Norway, highlighting trends in utilization over three seasons and differences in application between hospitals.
Background
Bronchiolitis is a common respiratory condition in infants, leading to significant hospitalizations. Effective management is crucial to reduce the burden on pediatric departments. The introduction of HFNC as a non-invasive respiratory support option has changed treatment approaches.
Data Highlights
No numerical data provided in the source material.
Key Findings
2%-3% of infants are hospitalized for bronchiolitis in their first year of life.
Standard oxygen therapy (SOT) is commonly used for mild to moderate respiratory distress.
CPAP has historically been used as a rescue therapy for infants not responding to SOT.
HFNC is increasingly preferred over CPAP due to better tolerance and fewer side effects.
Clear guidelines for the use of HFNC and CPAP are needed.
Clinical Implications
The findings indicate a shift towards HFNC in managing bronchiolitis. However, the need for standardized guidelines is emphasized.
Conclusion
The study highlights the evolving landscape of respiratory support for bronchiolitis in infants.
by Knut Øymar, Joel Selvakumar, Maren Våland Øymar, Ingvild Dalen, Ken Erik Klaseie, Ujinthini Sivanantham, Kasper Øvsthus, Inger Heimdal, Kari Holte, Kari Risnes, Ketil Størdal, Claus Klingenberg
